[The effect of biphenyl dimethyl dicarboxylate (DDB) on the fluidity of human erythrocyte membrane].
L Chen, W W Chen
Abstract
L Chen, W W Chen
Abstract
This paper deals with the effects of DDB on human RBC membrane fluidity as reflected by changes in the phase transition temperature and microviscosity monitored by ANS, NPN and DPH. The results showed that DDB decreased the fluidity of the shallow layer (ANS as probe), but increased the fluidity of the middle layer (NPN as probe) and deeper layer (DPH as probe). In addition, the drug was found to inhibit the hemolysis induced by MDA.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This paper deals with the effects of DDB on human RBC membrane fluidity as reflected by changes in the phase transition temperature and microviscosity monitored by ANS, NPN and DPH. The results showed that DDB decreased the fluidity of the shallow layer (ANS as probe), but increased the fluidity of the middle layer (NPN as probe) and deeper layer (DPH as probe). In addition, the drug was found to inhibit the hemolysis induced by MDA.
Key concepts: Microviscosity, Membrane fluidity, Chemistry, Hemolysis, Membrane, Biphenyl, Biophysics, Erythrocyte membrane